Umeclidinium
Umeclidinium. Inhaled LAMA — once-daily M3-preferring muscarinic antagonist for COPD. Component of triple-therapy inhalers (Trelegy =… Inhaled half-life 11 h.
Inhaled LAMA — once-daily M3-preferring muscarinic antagonist for COPD. Component of triple-therapy inhalers (Trelegy = umeclidinium + vilanterol + fluticasone furoate). Quaternary structure limits systemic absorption.